1,641
Views
17
CrossRef citations to date
0
Altmetric
Vaccines

The use of Zostavax in Spain: the economic case for vaccination of individuals aged 50 years and older

, , , , &
Pages 576-586 | Received 15 Oct 2015, Accepted 21 Jan 2016, Published online: 02 Mar 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Sariya Udayachalerm, Maranda G. Renouard, Thunyarat Anothaisintawee, Ammarin Thakkinstian, Sajesh K. Veettil & Nathorn Chaiyakunapruk. (2022) Incremental net monetary benefit of herpes zoster vaccination: a systematic review and meta-analysis of cost-effectiveness evidence. Journal of Medical Economics 25:1, pages 26-37.
Read now
George N. Okoli, Yahya Al-Yousif, Viraj K. Reddy, Mê-Linh Lê, Christine J. Neilson & Ahmed M. Abou-Setta. (2022) The Number Needed to Vaccinate (NNV) against herpes zoster: a systematic review with meta-analysis. Infectious Diseases 54:5, pages 356-366.
Read now
Cintia Muñoz-Quiles, Mónica López-Lacort, F. Javier Ampudia-Blasco & Javier Díez-Domingo. (2017) Risk and impact of herpes zoster on patients with diabetes: A population-based study, 2009–2014. Human Vaccines & Immunotherapeutics 13:11, pages 2606-2611.
Read now
Patricia R. Blank, Zanfina Ademi, Xiaoyan Lu, Thomas D. Szucs & Matthias Schwenkglenks. (2017) Herpes zoster vaccine: A health economic evaluation for Switzerland. Human Vaccines & Immunotherapeutics 13:7, pages 1495-1504.
Read now

Articles from other publishers (13)

Diego Morena, Sara Lumbreras, José Miguel Rodríguez, Carolina Campos, María Castillo, María Benavent & José Luis Izquierdo. (2023) Chronic Respiratory Diseases as a Risk Factor for Herpes Zoster Infection. Archivos de Bronconeumología 59:12, pages 797-804.
Crossref
Marta Corcuera-Munguia, Ruth Gil-Prieto, Rafael Garcia-Carretero & Angel Gil-de-Miguel. (2022) Hospitalization Burden Related to Herpes Zoster Infection in Spain (2016–2019). Infectious Diseases and Therapy 12:1, pages 143-156.
Crossref
Antonio J. García Ruiz, Mª Luz González Álvarez, Nuria García-Agua Soler & Francisco Jódar Sánchez 0000-0003-1092-9932. 2022. Vacunas contra el Herpes Zóster: El calor de las vacunas en la nueva era. Vacunas contra el Herpes Zóster: El calor de las vacunas en la nueva era.
Catherina X. Pan, Michelle S. Lee & Vinod E. Nambudiri. (2022) Global herpes zoster incidence, burden of disease, and vaccine availability: a narrative review. Therapeutic Advances in Vaccines and Immunotherapy 10, pages 251513552210845.
Crossref
Molly Sauer, Prarthana Vasudevan, Ankita Meghani, Karuna Luthra, Cristina Garcia, Maria Deloria Knoll & Lois Privor-Dumm. (2021) Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries. Vaccine 39:11, pages 1556-1564.
Crossref
James F Mbinta, Binh P Nguyen, Prosper Mandela A Awuni, Paul E Eme & Colin R Simpson. (2021) Postlicensure herpes zoster vaccine effectiveness: systematic review protocol. BMJ Open 11:2, pages e040964.
Crossref
Edward T. Chiyaka, Van T. Nghiem, Lu Zhang, Abhishek Deshpande, Patricia Dolan Mullen & Phuc Le. (2018) Cost-Effectiveness of Herpes Zoster Vaccination: A Systematic Review. PharmacoEconomics 37:2, pages 169-200.
Crossref
Cintia Muñoz-Quiles, Mónica López-Lacort & Javier Díez-Domingo. (2018) Risk and impact of herpes zoster among COPD patients: a population-based study, 2009–2014. BMC Infectious Diseases 18:1.
Crossref
Joke Bilcke, Frederik Verelst & Philippe Beutels. (2018) Sponsorship Bias in Base-Case Values and Uncertainty Bounds of Health Economic Evaluations? A Systematic Review of Herpes Zoster Vaccination. Medical Decision Making 38:6, pages 730-745.
Crossref
Katarzyna Rygiel. (2017) Comprehensive Assessment and Pharmacotherapy of Patients with Chronic Pain Syndrome Due to Diabetic Neuropathy and Postherpetic Neuralgia. European Medical Journal, pages 35-41.
Crossref
Shu-ling Hoshi, Masahide Kondo & Ichiro Okubo. (2017) Cost-effectiveness of varicella vaccine against herpes zoster and post-herpetic neuralgia for elderly in Japan. Vaccine 35:24, pages 3264-3271.
Crossref
Esther Redondo Margüello, Dídac Mauricio, José Javier Mediavilla Bravo, Alfonso Soto González, Elías Delgado Álvarez, F. Javier Ampudia-Blasco & Esteban Jódar Gimeno. (2016) ZODIAC: Consenso para la prevención del herpes zóster en personas con diabetes mellitus. SEMERGEN - Medicina de Familia 42, pages 1-19.
Crossref
Gillian M. Keating. (2016) Shingles (Herpes Zoster) Vaccine (Zostavax®): A Review in the Prevention of Herpes Zoster and Postherpetic Neuralgia. BioDrugs 30:3, pages 243-254.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.